
Dukinase 25000IU Injection
Marketer
Taj Pharma India Ltd
Salt Composition
Urokinase (25000IU)
Overview Dukinase 25000IU Injection
Thrombolytic agent Dukinase, 25000IU injection, dissolves dangerous blood clots obstructing blood vessels. It's indicated for post-myocardial infarction treatment and manages conditions like pulmonary embolism and ischemic stroke. Administration requires strict physician oversight; dosage and treatment length are determined individually. Close monitoring is typical until patient stabilization. Potential side effects include nausea, vomiting, injection site hemorrhage, allergic responses, and hypotension. Increased bleeding risk is possible. Your physician will discuss the treatment's benefits and risks prior to administration. Continue all prescribed long-term medications. Caution is advised in patients with bleeding disorders, hepatic or renal impairment. Disclose any existing conditions, pregnancy, breastfeeding, or other medications currently in use to your doctor.
Uses of Dukinase 25000IU Injection
Myocardial infarction or blood clot in the lungs
Major Benefits of Dukinase 25000IU Injection:
Administering this medication is solely the responsibility of your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Dukinase 25000IU Injection:
- Allergic reaction
- Nausea
- Vomiting
- Injection site bleeding
- Decreased blood pressure
How to use Dukinase 25000IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Dukinase 25000IU Injection works:
Dukinase 25000IU Injection breaks down dangerous blood clots within blood vessels, re-establishing blood flow to compromised tissues. This action prevents tissue necrosis and improves patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while using Dukinase 25000IU Injection is undetermined. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Dukinase 25000IU is typically regarded as safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; however, clinical data from human trials are currently scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Dukinase 25000IU Injection during lactation is likely safe. Available human data indicates minimal risk to the nursing infant.
DrivingNOT RELEVANT
Inapplicable, given that Dukinase 25000IU Injection is administered solely within a hospital setting.
KidneySAFE IF PRESCRIBED
The use of Dukinase 25000IU Injection in patients with kidney disease is likely safe, with limited evidence suggesting dosage modification isn't necessary. However, medical advice is crucial. Dukinase 25000IU Injection is contraindicated for individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Dukinase 25000IU Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dukinase 25000IU Injection :
Should you forget a Dukinase 25000IU Injection, seek your physician's advice.
Facts to Know About Dukinase 25000IU Injection
| Label | Value |
|---|---|
| Chemical Type | Amino acid and peptide analogs |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | Early Thrombolytic Agents |
